Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : Zharp2-1
Catalog No.: PC-21082Not For Human Use, Lab Use Only.
Zharp2-1 is a novel potent, selective RIPK2 inhibitor with IC50 of 38.5 nM in ADP-Glo kinase assay, effectively blocks RIPK2 kinase function and NOD-mediated NF-κB/MAPK activation.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Zharp2-1 is a novel potent, selective RIPK2 inhibitor with IC50 of 38.5 nM in ADP-Glo kinase assay, effectively blocks RIPK2 kinase function and NOD-mediated NF-κB/MAPK activation.
Zharp2-1 has a high affinity to RIPK2 (Kd=3.1 nM) in binding assay.
Zharp2-1 shows no significant binding to RIPK1 with Kd of >30,000 nM or RIPK3 with Kd of 710 nM, does not affect the kinase activity of RIPK1 and RIPK3 even at 1 μM.
Zharp2-1 efficiently inhibits pro-inflammatory cytokine IL-8 in THP-1 cells with an IC50 of 6.4 nM stimulated by L18-MDP and an IC50 of 16.4 nM stimulated by MDP.
Zharp2-1 blocks cellular NOD-mediated activation of MAPK/NF-κB signaling pathway.
Zharp2-1 significantly inhibits MDP-induced cytokine release in PBMCs, with an IC50 of 0.8 nM for IL-8, 8.7 nM for IL-6 and 11.9 nM for TNF-α, exerts a higher efficacy compared to GSK2983559 (Cat# PC-73178).
Zharp2-1 (15 mg/kg, once daily by oral gavage for 6 day) significantly alleviates inflammatory bowel disease in rat model of colitis induced by dinitrobenzene sulfonic acid (DNBS).
| M.Wt | 383.41 | |
| Formula | C19H18N3O2PS | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Yujun Lai, et al. Biochem Pharmacol. 2023 Aug;214:115647.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
